Previously, we used animal MRI/MRS measurements and showed that NAA declines in the hippocampus in APP/PS1 mice during moderate-severe pathological stages [24], suggesting that abnormal AD changes in cholinergic metabolism impair cholinergic activity and the integrity of cholinergic neurons in the basal forebrain and hippocampus. Here, APP is linked to Alzheimer disease.